Announcements Trials

Browse Landscape

Phase

Status

Terminated 2 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 11 Carcinoma, Non-Small-Cell Lung 11 Carcinoma, Transitional Cell 9 Carcinoma, Renal Cell 8 Colorectal Neoplasms 7 Urinary Bladder Neoplasms 6 Ovarian Neoplasms 6 Neoplasm Metastasis 6 Squamous Cell Carcinoma of Head and Neck 4 Recurrence 3 Glioblastoma 3 Carcinoma, Neuroendocrine 3 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Sarcoma 2 Neuroendocrine Tumors 2 Kidney Neoplasms 2 Kidney Diseases 2 Head and Neck Neoplasms 2 Glioma 2 Fallopian Tube Neoplasms 2 Carcinoma, Merkel Cell 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Urothelial Cancer 1 Urologic Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Testicular Neoplasms 1 Testicular Diseases 1

Interventions

Cisplatin 33 Radiotherapy 23 Cetuximab 18 Paclitaxel 14 Docetaxel 14 pembrolizumab 13 Carboplatin 12 Fluorouracil 10 Radiotherapy, Intensity-Modulated 8 Nivolumab 8 Drug Therapy 7 Erlotinib Hydrochloride 6 Panitumumab 5 dacomitinib 4 Radiation 4 Methotrexate 4 Esophagectomy 4 130-nm albumin-bound paclitaxel 4 durvalumab 3 ON 01910 3 Leucovorin 3 Gemcitabine 3 Chemoradiotherapy 3 vandetanib 2 palbociclib 2 osimertinib 2 nedaplatin 2 fludarabine 2 cabazitaxel 2 atezolizumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Carcinoma, Squamous Cell × avelumab × Clear all

NCT03494322 2026-05-20

EACH

University College, London

Phase 2 Completed

Carcinoma, Squamous Cell, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡